Breakdown | |||||
TTM | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
---|---|---|---|---|---|
Income Statement | Total Revenue | ||||
239.50M | 241.40M | 247.10M | 195.20M | 165.30M | 189.40M | Gross Profit |
117.40M | 32.40M | 161.80M | 129.80M | 104.50M | 121.10M | EBIT |
27.70M | 26.70M | 22.90M | 16.20M | 8.10M | 10.10M | EBITDA |
36.60M | 38.40M | 31.70M | 23.80M | 19.00M | 19.10M | Net Income Common Stockholders |
14.50M | 17.10M | 11.80M | 10.20M | 4.60M | 1.90M |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | ||||
16.40M | 17.80M | 19.30M | 10.50M | 19.90M | 15.60M | Total Assets |
198.10M | 238.00M | 249.70M | 195.10M | 194.80M | 216.00M | Total Debt |
33.30M | 57.80M | 68.80M | 35.80M | 53.20M | 68.80M | Net Debt |
16.90M | 40.00M | 49.50M | 25.30M | 33.30M | 53.20M | Total Liabilities |
190.30M | 187.80M | 210.60M | 189.30M | 200.90M | 216.40M | Stockholders Equity |
5.10M | 50.20M | 39.10M | 5.80M | -6.10M | -400.00K |
Cash Flow | Free Cash Flow | ||||
24.00M | 22.00M | 8.30M | 14.00M | 23.60M | 1.70M | Operating Cash Flow |
35.30M | 32.20M | 16.70M | 19.30M | 26.70M | 10.90M | Investing Cash Flow |
-36.00M | -14.80M | -22.90M | -5.60M | -2.90M | -11.00M | Financing Cash Flow |
1.50M | -20.10M | 14.10M | -21.90M | -22.30M | -2.70M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
80 Outperform | £4.78B | 19.20 | 23.66% | 2.47% | 0.48% | -1.96% | |
77 Outperform | £1.77B | 26.70 | 4.83% | 5.57% | 49.59% | 18.13% | |
74 Outperform | £598.48M | 12.10 | 14.06% | 5.70% | -1.26% | 6.56% | |
72 Outperform | £1.36B | ― | -2.02% | 2.35% | -5.23% | -301.98% | |
71 Outperform | £293.64M | 6.23 | 21.08% | 6.14% | -10.24% | -11.60% | |
69 Neutral | £161.26M | ― | ― | ― | ― | ||
66 Neutral | $4.49B | 12.34 | 5.40% | 248.65% | 4.13% | -12.33% |